Aino Health AB (publ) (AINO.ST)
SEK 0.14
(0.0%)
SEK 0.14
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 164 Thousand SEK | -75.11% |
| 2022 | 659 Thousand SEK | -37.89% |
| 2021 | 1.06 Million SEK | -28.65% |
| 2020 | 1.48 Million SEK | 305.18% |
| 2019 | 367 Thousand SEK | 46.8% |
| 2018 | 250 Thousand SEK | -63.87% |
| 2017 | 692 Thousand SEK | 17.49% |
| 2016 | 589 Thousand SEK | -66.67% |
| 2015 | 1.76 Million SEK | -25.35% |
| 2014 | 2.36 Million SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 171 Thousand SEK | 4.27% |
| 2024 Q2 | 168 Thousand SEK | -1.75% |
| 2023 Q3 | 681 Thousand SEK | -2.58% |
| 2023 Q2 | 699 Thousand SEK | 4.64% |
| 2023 Q1 | 668 Thousand SEK | 1.37% |
| 2023 FY | 164 Thousand SEK | -75.11% |
| 2023 Q4 | 164 Thousand SEK | -75.92% |
| 2022 Q3 | 1.13 Million SEK | 2.17% |
| 2022 Q1 | 1.07 Million SEK | 1.04% |
| 2022 FY | 659 Thousand SEK | -37.89% |
| 2022 Q4 | 659 Thousand SEK | -41.78% |
| 2022 Q2 | 1.1 Million SEK | 3.36% |
| 2021 Q3 | 1.51 Million SEK | 0.73% |
| 2021 FY | 1.06 Million SEK | -28.65% |
| 2021 Q4 | 1.06 Million SEK | -29.78% |
| 2021 Q2 | 1.5 Million SEK | -1.12% |
| 2021 Q1 | 1.51 Million SEK | 2.02% |
| 2020 Q4 | 1.48 Million SEK | -29.46% |
| 2020 FY | 1.48 Million SEK | 305.18% |
| 2020 Q1 | 374 Thousand SEK | 1.91% |
| 2020 Q2 | 2.09 Million SEK | 460.43% |
| 2020 Q3 | 2.1 Million SEK | 0.57% |
| 2019 FY | 367 Thousand SEK | 46.8% |
| 2019 Q1 | 769 Thousand SEK | 207.6% |
| 2019 Q4 | 367 Thousand SEK | -2.65% |
| 2019 Q3 | 377 Thousand SEK | 1.62% |
| 2019 Q2 | 371 Thousand SEK | -51.76% |
| 2018 Q1 | 1.08 Million SEK | 56.79% |
| 2018 FY | 250 Thousand SEK | -63.87% |
| 2018 Q4 | 250 Thousand SEK | -74.41% |
| 2018 Q3 | 977 Thousand SEK | 33.29% |
| 2018 Q2 | 733 Thousand SEK | -32.44% |
| 2017 Q3 | 1 Million SEK | -1.85% |
| 2017 FY | 692 Thousand SEK | 17.49% |
| 2017 Q1 | 1 Million SEK | 70.97% |
| 2017 Q4 | 692 Thousand SEK | -31.42% |
| 2017 Q2 | 1.02 Million SEK | 2.09% |
| 2016 Q3 | 1.86 Million SEK | 0.0% |
| 2016 Q4 | 589 Thousand SEK | -68.4% |
| 2016 FY | 589 Thousand SEK | -66.67% |
| 2015 FY | 1.76 Million SEK | -25.35% |
| 2014 FY | 2.36 Million SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Bonzun AB (publ) | 554 Thousand SEK | 70.397% |
| Kontigo Care AB (publ) | 3.67 Million SEK | 95.537% |
| Medhelp Care Aktiebolag (publ) | - SEK | -Infinity% |
| RaySearch Laboratories AB (publ) | 431.97 Million SEK | 99.962% |
| Surgical Science Sweden AB (publ) | 40.02 Million SEK | 99.59% |